Sign in
4

Changes in Ownership

Gain Therapeutics, Inc. Filed Acc 0001493152-24-011215

Options or other derivatives

  • Chief Executive Officer acquired 370,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Alder Matthias · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-03-21 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +370,000 370,000 D
Loading xslF345X05/ownership.xml…